Evidence map›Paper›PMID 28069097›Full record

ArticleJournal of the International Neuropsychological Society : JINS2017

Cognitive Outcome in Childhood-Onset Epilepsy: A Five-Decade Prospective Cohort Study.

Mira Karrasch, Petri Tiitta, Bruce Hermann, Juho Joutsa, Shlomo Shinnar, Juha Rinne, Anu Anttinen, Matti Sillanpää

Open access · greenAbstract read
In one paragraph

Article in Journal of the International Neuropsychological Society : JINS, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Language Dysfunction in Pediatric Epilepsy.The Journal of pediatrics · 2018
    Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Mira Karrasch1Department of Psychology,Åbo Akademi University,Turku,Finland.
Petri Tiitta2Department of Public Health,University of Turku,Finland.
Bruce Hermann4Department of Neurology,University of Wisconsin School of Medicine and Public Health,Madison,Wisconsin.
Juho Joutsa5Turku PET Centre,University of Turku and Turku University Hospital,Finland.
Shlomo Shinnar6Division of Clinical Neurosciences,University of Turku and Turku University Hospital,Finland.
Juha Rinne5Turku PET Centre,University of Turku and Turku University Hospital,Finland.
Anu Anttinen7Department of Clinical Neurophysiology,University of Turku and Turku University Hospital,Finland.
Matti Sillanpää9Departments of Public Health and Child Neurology,University of Turku,Finland.
University of Turku · FIÅbo Akademi University · FIAlbert Einstein College of Medicine · USTurku University Hospital · FIUniversity of Wisconsin–Madison · US

Funding

Wisconsin Registry for Alzheimer's Prevention: Sex Differences in DNA MethylationR01AG027161 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Nathaniel Ark Chin, Sterling C Johnson · 2007 to 2026
$35.6M
Impact of Initial Therapy and Response on Long Term Outcome in Children with CAEU01NS045911 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI GLAUSER, TRACY A · 2003 to 2013
$31.1M
Established Status Epilepticus Treatment Trial (ESETT)U01NS088034 · NINDS · UNIVERSITY OF VIRGINIA · PI CHAMBERLAIN, JAMES, KAPUR, JAIDEEP · 2014 to 2018
$16.3M
Consequences of Prolonged Febrile Seizures in ChildhoodR37NS043209 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SHINNAR, SHLOMO · 2013 to 2019
$11.4M
Neuropsychological Progression of New Onset EpilepsyR01NS044351 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI HERMANN, BRUCE PHILLIP · 2003 to 2015
$6.3M
Einstein Center for Excellence for Clinical Trials in NeuroscienceU10NS077308 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI LIPTON, RICHARD B., SHINNAR, SHLOMO · 2011 to 2017
$2.2M
Structural Stability of Carotid Plaque and SymptomatologyR01NS064034 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI DEMPSEY, ROBERT J · 2010 to 2014
$1.5M
NIA NIH HHS R01 AG027161NINDS NIH HHS R01 NS044351NINDS NIH HHS R01 NS064034NINDS NIH HHS R37 NS043209NINDS NIH HHS U01 NS045911NINDS NIH HHS U01 NS088034NINDS NIH HHS U10 NS077308
6 · The paper itself

Abstract

objectivesLittle is known about the very long-term cognitive outcome in patients with childhood-onset epilepsy. The aim of this unique prospective population-based cohort study was to examine cognitive outcomes in aging participants with childhood-onset epilepsy (mean onset age=5.3 years) five decades later (mean age at follow-up=56.5 years).

methodsThe sample consisted of 48 participants with childhood-onset epilepsy and 48 age-matched healthy controls aged 48-63 years. Thirty-six epilepsy participants were in remission and 12 continued to have seizures. Cognitive function was examined with 11 neuropsychological tests measuring language and semantic function, episodic memory, and learning, visuomotor function, executive function, and working memory.

resultsThe risk of cognitive impairment was very high in participants with continuing seizures; odds ratio (OR)=11.7 (95% confidence interval [CI] (2.8, 49.6), p=.0008). They exhibited worse performances across measures of language and semantic function, and visuomotor function compared to participants with remitted epilepsy and healthy controls. In the participants with remitted epilepsy, the risk of cognitive impairment was somewhat elevated, but not statistically significant; OR=2.6 (95% CI [0.9, 7.5], p=.08).

conclusionsOur results showed that the distinction of continued versus discontinued seizures was critical for determining long-term cognitive outcome in childhood-onset epilepsy. Few participants in remission exhibited marked cognitive impairment compared to age-matched peers. However, a subgroup of participants with decades long active epilepsy, continuous seizure activity and anti-epileptic drug (AED) medication, showed clinically significant cognitive impairment and are thus in a more precarious position when entering older age. (JINS, 2017, 23, 332-340).

Indexed as

AgingDisease ProgressionAge of OnsetCognitive DysfunctionEpilepsyFemaleFollow-Up StudiesHumansMaleMiddle AgedAgingLanguageNeuropsychologySeizureSemantic functionVisuomotor function

Identifiers

PMID28069097
PMCPMC6893911
OpenAlexW2568271088

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.